Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.0797
Abstract: Key Points Question Do county-level rates of liver metastasectomy for colorectal liver metastasis (CRLM) vary geographically in the US based on county-level socioeconomic characteristics? Findings In this cross-sectional study of 194 US counties and 11 348… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2018.2107
Abstract: Importance Surgery represents the mainstay treatment of colorectal liver metastases. Indications for the laparoscopic approach in this setting have been widened and there is a need to confirm the benefits of minimally invasive liver surgery… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "British Journal of Surgery"
DOI: 10.1002/bjs.10457
Abstract: Detailed knowledge about the proportion of patients with colorectal liver metastases (CLM) undergoing resection is sparse. The aim of this study was to analyse cumulative resection rates and survival in patients with CLM. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10822
Abstract: Although perihepatic lymph node metastases (PLNMs) are known to be a poor prognosticator for patients with colorectal liver metastases (CRLMs), optimal management remains unclear. This study aimed to determine the risk factors for PLNMs, and… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10834
Abstract: Despite a 5‐year overall survival rate of 58 per cent after liver resection for colorectal liver metastases (CLMs), more than half of patients develop recurrence, highlighting the need for accurate risk stratification and prognostication. Traditional… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.33924
Abstract: The recurrence rate of colorectal liver metastases (CRLM) patients treated with curative intent is above 50%. Standard of care surveillance includes intensive computed tomographic (CT) imaging as well as carcinoembryonic antigen (CEA) measurements. Nonetheless, relapse… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.12358
Abstract: Most prognostic scoring systems for colorectal liver metastases (CRLMs) account for factors related to tumour biology. Little is known about the effects of the host phenotype to the tumour. Our objective was to delineate the… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24631
Abstract: There is ongoing debate about whether patients planned for liver resection of colorectal liver metastases (CRLM) benefit from neoadjuvant chemotherapy (NC). Therefore, we performed a retrospective survival analysis of patients with and without NC prior… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24671
Abstract: The use of liver transplantation (LT) for liver metastases attempted in the early 1990's was associated with poor perioperative outcomes and unacceptably low overall survival. Recently, there has been renewed interest in LT as a… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24678
Abstract: Recently, a tumor‐burden “metro ticket” score (TBS) based on final pathology was proposed to predict outcome following resection of colorectal liver metastasis (CRLM). We sought to validate the TBS prognostic tool using preoperative radiologic cross‐sectional… read more here.